{
  "ticker": "AVTX",
  "success": true,
  "price": {
    "current": 15.25,
    "currency": "USD",
    "day_high": 15.41,
    "day_low": 14.82,
    "52_week_high": 20.72,
    "52_week_low": 3.39
  },
  "market_cap": {
    "value": 282319520.0,
    "currency": "USD"
  },
  "shares_outstanding": 18512757.0,
  "volume": {
    "last": 273066,
    "average_30d": 317353
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -3.3505952,
    "price_to_book": 2.9698148
  },
  "company_info": {
    "name": "Avalo Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 125100000.0,
    "total_liabilities": 33553000.0,
    "stockholders_equity": 91547000.0,
    "cash": 26963000.0,
    "marketable_securities": 84654000.0,
    "total_liquidity": 111617000.0,
    "total_debt": 555000.0,
    "long_term_debt": 117000.0,
    "current_debt": 438000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -16365000.0,
    "free_cash_flow": -16365000.0,
    "investing_cash_flow": -13261000.0,
    "financing_cash_flow": 14369000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 19198000.0,
    "research_and_development": 13621000.0,
    "interest_expense": null,
    "net_income": -30625000.0,
    "revenue": 0.0,
    "gross_profit": 0.0,
    "ebitda": -19139000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:47:28.815163",
    "url": "https://finance.yahoo.com/quote/AVTX",
    "data_hash": "bbf849ce9e04f07e"
  }
}